| abstract |
The present invention relates to neurodegenerative diseases (eg, ischemic or hemorrhagic stroke, focal and global ischemia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis) The provision of a pharmaceutical composition for the prevention and treatment of sickness). A pharmaceutical preparation comprising α-lipoic acid, ambroxol and / or angiotensin converting enzyme (ACE) inhibitor and its use for treating neurodegenerative diseases. [Selection diagram] None |